Targeting NFE2L2 regulates the expression of TFRC, FTH1 and GPX4, induces the increase of unstable iron and the depletion of GPX4, which is an important mechanism of orexin‐A‐mediated GBM ferroptosis. The gene discussed is FTH1; the disease is glioblastoma.